Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.2803
Delayed Data
As of Feb 12
 +0.0003 / +0.11%
Today’s Change
0.27
Today|||52-Week Range
1.73
-26.62%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.28
Today’s open0.30
Day’s range0.28 - 0.30
Volume168,273
Average volume (3 months)677,909
Market cap$18.3M
Dividend yield--
Data as of 3:57pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+73.42%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book5.28

Competitors

 Today’s
change
Today’s
% change
RGBPRegen BioPharma Inc-0.00-0.97%
ROSGRosetta Genomics Ltd+0.01+1.27%
OXGNOXiGENE Inc+0.04+8.00%
SNGXSoligenix Inc-0.01-1.20%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts

Partner Offers